Skip to main content
Equibles
XTNT logo

XTNT · Xtant Medical Holdings, Inc. · Metrics

Track XTNT — free

Use XTNT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XTNT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.35 +0.00 (+0.55%) At close · Sep 11
Rebalance outlook locked
Market Cap
$48.51M
Shares
140.29M

XTNT metrics

79 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.35
Market cap
$48.51M

Price action

20 metrics
Price change (1W)
-13.1%
Price change (30D)
+10.2%
Price change (3M)
-20.0%
Price change (6M)
-42.7%
Price change (YTD)
-55.9%
Price change (1Y)
-44.5%
Trailing year
Price change (5Y)
-71.6%
52-week high
$0.92
52-week low
$0.31
Change from 52-week high
-62.6%
Change from 52-week low
+12.8%
Annualized volatility
65.6%
Annualized volatility (3M)
87.1%
Beta
0.6
RSI (14D)
43.7
Price vs SMA 50
-12.6%
Price vs SMA 200
-35.0%
Avg volume (3M)
1.68M
Relative volume
0.2
Average dollar volume
$640,727

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
140.29M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 233.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 239.6%
P / book
1.1
reciprocal yield 87.5%
FCF yield
-1.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
80.2
reciprocal yield 1.2%
Earnings yield
-24.4%

Historical valuation

8 metrics
P / E historical average (3Y)
60.6×
reciprocal yield 1.6%
P / E historical average (5Y)
60.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 108.4%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 92.6%
EV / EBIT historical average (3Y)
897.2×
reciprocal yield 0.1%
EV / EBIT historical average (5Y)
758.8×
reciprocal yield 0.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
22.4×
reciprocal yield 4.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
59.4%
Operating margin
-9.6%
Trailing 12 months
Net margin
-10.2%
Gross profit (TTM)
$65.05M
Operating profit (TTM)
−$10.49M
Net income (TTM)
−$11.14M
Trailing 12 months
Diluted EPS (TTM)
$-0.08
FCF margin
-0.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.36

Growth

11 metrics
Revenue growth YoY
-35.0%
Year over year
Net income growth YoY
-365.2%
Revenue (TTM)
$109.53M
Trailing 12 months
EPS growth YoY
-450.0%
Shares change YoY
-5.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+32.2%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-27.8%
Return on assets
-14.0%
Debt / equity
0.3
Current ratio
2.2
EBITDA (TTM)
−$6.47M
Free cash flow (TTM)
−$696,000
Quick ratio
1.1
Interest coverage
-3.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.14M
Latest balance sheet
Cash & equivalents
$9.87M
Total assets
$79.67M
Total debt
$11.01M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$570,000
Capital expenditures (TTM)
$1.27M
R&D (TTM)
$2.22M
SG&A (TTM)
—
Stock compensation (TTM)
$2.96M
R&D / revenue
2.0%
Stock compensation / revenue
2.7%

Ownership (13F)

3 metrics
13F filers
32
13F filer change QoQ
-2
Institutional ownership
57.2%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1453593 CUSIP 98420P308 13F (30d) 20 filings 20 filers Visit website Investor relations